Paroxysmal AV block primary prevention: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(One intermediate revision by the same user not shown)
Line 4: Line 4:
{{CMG}}; {{AE}}{{Akash}}
{{CMG}}; {{AE}}{{Akash}}
==Overview==
==Overview==
There are no established measures for the primary prevention of [disease name].
There are no established measures for the primary prevention of [[paroxysmal AV Block]].
 
OR
 
There are no available vaccines against [disease name].
 
OR
 
Effective measures for the primary prevention of [disease name] include [measure1], [measure2], and [measure3].
 
OR
 
[Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include [strategy 1], [strategy 2], and [strategy 3].


==Primary Prevention==
==Primary Prevention==
There are no established measures for the primary prevention of [disease name].
There are no established measures for the primary prevention of [[paroxysmal AV Block]].
 
OR
 
There are no available vaccines against [disease name].
 
OR
 
Effective measures for the primary prevention of [disease name] include:
*[Measure1]
*[Measure2]
*[Measure3]
 
OR
 
[Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include:
*[Strategy 1]
*[Strategy 2]
*[Strategy 3]


==References==
==References==

Latest revision as of 08:07, 11 July 2020

Paroxysmal AV block Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Paroxysmal AV block from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Paroxysmal AV block primary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Paroxysmal AV block primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Paroxysmal AV block primary prevention

CDC on Paroxysmal AV block primary prevention

Paroxysmal AV block primary prevention in the news

Blogs on Paroxysmal AV block primary prevention

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Paroxysmal AV block primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Akash Daswaney, M.B.B.S[2]

Overview

There are no established measures for the primary prevention of paroxysmal AV Block.

Primary Prevention

There are no established measures for the primary prevention of paroxysmal AV Block.

References


Template:WH Template:WS